CLINICAL CHARACTERISTICS, MICROBIOLOGY, AND ANTIBIOTIC RESISTANCE PATTERNS OF BACTERIA CAUSING HOSPITAL-ACQUIRED PNEUMONIA IN THE RESPIRATORY DEPARTMENT OF PEOPLE’S HOSPITAL 115
Main Article Content
Abstract
Background: Hospital-acquired pneumonia (HAP) is one of the most common nosocomial infections and a leading cause of mortality among hospitalized patients. Early initiation of appropriate antimicrobial therapy guided by local resistance patterns is essential for effective management. This study aimed to describe the clinical characteristics, microbiological profile, and antimicrobial resistance patterns of pathogens causing HAP in the Respiratory Department of People’s Hospital 115. Methods: A descriptive case series was conducted among 38 patients diagnosed with HAP between March 2024 and September 2024. HAP was defined according to the 2016 Infectious Diseases Society of America (IDSA) criteria. Demographic data, clinical manifestations, laboratory findings, microbiological results, and in-hospital outcomes were collected and analyzed. Results: The mean age was 73 ± 2 years, and 55.3% of patients were female. Invasive mechanical ventilation was required in 65.8% of patients, while septic shock occurred in 50%. The sputum culture positivity rate was 73.7%, and blood cultures were positive in 23.7% of cases. Gram-negative bacteria predominated (92.8%), with Klebsiella spp. (60.7%) being the most common pathogen, followed by A. baumannii (17.6%), E. coli (7.2%), and Pseudomonas aeruginosa (3.6%). Gram-positive pathogens included methicillin-resistant Staphylococcus aureus (3.6%) and Streptococcus pneumoniae (3.6%). Multidrug-resistant organisms were identified in 78.6% of isolates, including multidrug-resistant (MDR) strains in 13.6% and extensively drug-resistant (XDR) strains in 86.4%, with no pandrug-resistant (PDR) isolates detected. All multidrug-resistant isolates were gram-negative bacteria. Among these, Klebsiella spp. accounted for 59%, followed by A. baumannii (22.7%), E. coli (9%), P. aeruginosa (4.5%), and Enterococcus spp. (4.5%). Klebsiella spp. demonstrated high resistance rates to most antibiotics, including amoxicillin (100%), piperacillin–tazobactam (100%), ceftriaxone (75%), ceftazidime (75%), meropenem (73.3%), imipenem (57.1%), amikacin (40%), and ciprofloxacin (84.6%), but remained susceptible to colistin. A. baumannii was resistant to all tested antibiotics and showed only intermediate susceptibility to colistin. Conclusions: Gram-negative bacteria, particularly Klebsiella spp., were the predominant pathogens and exhibited high levels of antimicrobial resistance, with the majority classified as XDR. Resistance rates were high for most antibiotics, with colistin remaining the only consistently active agent.
Keywords
Hospital acquired pneumonia, drug-resistant bacteria, antimicrobial resistance.
Article Details
References
2. Torres A, Niederman MS, Chastre J, et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT). Eur Respir J. Sep 2017;50(3)doi:10.1183/13993003.00582-2017
3. Kalil AC, Metersky ML, Klompas M, et al. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. Sep 1 2016;63(5):e61-e111. doi:10.1093/cid/ciw353
4. Beardsley JR, Williamson JC, Johnson JW, et al. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia. Chest. Sep 2006;130(3):787-93. doi:10.1378/chest.130.3.787
5. Kiếu PN. Đặc điểm vi khuẩn gây viêm phổi bệnh viện tại khoa Hồi sức tích cực và chống độc Bệnh viện đa khoa trung tâm An Giang. 2015
6. Dũng LT. Viêm Phổi Bệnh Viện: Ðặc Ðiểm Vi Khuẩn Và Đề Kháng Kháng Sinh In Vitro Tại Bệnh Viện Ðại Học Y Dược TPHCM. Tạp chí Thời sự Y học. 2017;(10)
7. Dominedò C, Ceccato A, Niederman M, et al. Predictive Performance of Risk Factors for Multidrug-Resistant Pathogens in Nosocomial Pneumonia. Ann Am Thorac Soc. May 2021;18(5):807-814. doi:10.1513/AnnalsATS.202002-181OC
8. Lê Bật Tân. Nghiên cứu đặc điểm lâm sàng, X quang phổi và vi khuẩn gây bệnh của viêm phổi bệnh viện ở người lớn điều trị tại bệnh viện Phổi trung ương. Luận án tiến sĩ y học. Đại học Y Hà Nội; 2018